Author: Marcus Essing

Netzwerk-Stipendium: Invitation to apply for a scholarship program

Academia Meets Industry (AMI) is an organization in support of pharmacy students at the University of Freiburg, Germany. There is an increasing awareness that pharmacy students who are interested in job perspectives in the pharma industry should be connected to this industry as early as possible during their studies.

In this context, AMI offers a “Netzwerkstipendium” to support students within Pharmaceutical Sciences (Master or Staatsexamen) and doctoral researchers at the pharmaceutical institute of the University of Freiburg.

The students within this program will be in close contact with an executive mentor working in the pharmaceutical industry. This person will provide advice to the student, make contacts for them and support them in their career planning. In addition AMI will grant 100€ per month as financial support covering for individual expenses.

Students and doctoral researchers at the faculty of pharmaceutical sciences especially those with an interest in drug development and regulatory affairs are eligible for this program. Participants will be chosen by our organization on an individual basis.

Written application including a vita should not exceed 2 pages. The application (PDF-file) should be sent to . Please also send a printed version to Prof. Dr. Andreas Bechthold, Universität Freiburg, Institut für Pharmazeutische Wissenschaften, Stefan-Meier-Str. 19, 79104 Freiburg

Deadline for the application is 12.11.2023.

 

Schedule of the association in 2023

  • Vorstandstreffen on 31.3.2023 online
  • Vorstandstreffen on 05.07.2023 f2f at location at Dr. Friederike Zahm
  • Get together with all lecturers on 9.5.2023 at location at Prof. Helmuth Laaff
  • Get together with students of the scholarship and mentors on 14.7.2023 at location Prof. Andreas Bechthold
  • Annual meeting of the association on 17.10.2023 at location at Institute of Dermatohistology, Pathology und Molekularpathology of Prof. Laaff

 

Master student Isabelle Roux rewarded by the German association for market access

In 2022, the German association for market access, Deutsche Fachgesellschaft für Market Access e.V., rewarded Isabelle Roux, one of our Master students for her Master thesis: Auswirkungen der bedingten Zulassung von Medikamenten auf die Erstattung in der EU.

This is an excellent example for the quality and high topicality of the Master theses within our program. Congrats to Isabelle!

 

The Phoenix Pharmacy Science Award 2021 at the Category Pharmaceutical Biology was awarded to Prof. Dr. A. Bechthold and his Research Group.

The research group is thus awarded for its outstanding work and publication “Secondary nucleotide messenger c-di-GMP exerts a global control on natural product biosynthesis in streptomycetes” in the journal “Nucleic Acid Research“, carried out by Dr. Roman Makitrynskyy, Olga Tsypik, Desirée Nuzzo of the working group in cooperation with Dr. Thomas Paululat, head of NMR facilities and research associate at the University of Siegen, and Prof. Dr. David L. Zechel, Department of Chemistry, Queen’s University, Kingston, Ontario, Canada under the direction of Prof. Dr. Andreas Bechthold.

 

Master’s program “Regulatory Affairs & Drug Development

At the winter semester and in further study years, there will be another opportunity to enroll in the unique Master’s program “Regulatory Affairs & Drug Development” at the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg. It is best to register with your study coordinator as soon as possible using this form.

Watch this video to find a short introduction into the study program.

You can find even more information about the master’s program via this recording of an information event about the master profile line from Mai of 2021. The recording also starts with the previous introduction video.

Interview with Prof. Dr. Andreas Bechthold, Executive Director of the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)

Interview with Prof. Dr. Helmut Laaff , CEO – Institut für Dermatohistology, Pathology, Molecular Pathology, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)

Interview with Daniela Dietz, Head of Regulatory ad Dr. Regenold GmbH, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)

Video Testimonials of (former) Students of the Master’s Program “Regulatory Affairs & Drug Development”